Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 5/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL8586502 | 0.85 | FDPS (0.39) | FDPSTSHRALDH1A1LMNAESR1 | |
| SCHEMBL7067005 | 0.85 | — | — | |
| SCHEMBL56456 | 0.85 | — | — | |
| SCHEMBL28146841 | 0.82 | FDPS (0.37) | FDPSTSHRALDH1A1LMNAESR1 | |
| Bromide SCHEMBL28675956 | 0.82 | — | — | |
| Ammonia Solution, Strong SCHEMBL11498771 | 0.82 | TSHR (0.40) | FDPSTSHRALDH1A1LMNAESR1 | |
| Ammonia Solution, Strong SCHEMBL28296666 | 0.82 | — | — | |
| Charcoal, Activated SCHEMBL8892440 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL1070655 | 0.82 | — | — | |
| SCHEMBL29219050 | 0.81 | OPRM1 (0.35) | TSHRLMNARIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6599894-B1 | Competitive inhibitors of trypsin-like proteases, such as thrombin, and in treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants | AstŕaZeneca AB (SE) | 2003-07-29 | — | — | US | disclosed |